The content on this site is intended for healthcare professionals only
For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
A new pathway to shrink cancerous tumours through body’s immune cells
Gene change explains chemo resistance in germ cell cancer
Enfortumab vedotin approved for locally advanced or metastatic urothelial cancer
Novel therapeutic agents may reduce the oncogenesis of metastatic prostate cancer
Lung cancer drug could improve survival rates for bladder cancer patients undergoing chemotherapy
Cancer-fighting viruses soften up their victims before attacking
NICE reverses recommendation allowing use of novel urothelial carcinoma immunotherapy on the NHS
Therapeutically effective drugs identified for bladder cancer
AACR 2022:Accounting for genetic factors that cause normal variations in PSA levels may improve the ...
AACR 2022: New CAR T-cell therapy for solid tumours was safe and showed early efficacy